725 related articles for article (PubMed ID: 29980853)
1. Dysfunctional inhibitory control in Parkinson's disease patients with levodopa-induced dyskinesias.
Picazio S; Ponzo V; Caltagirone C; Brusa L; Koch G
J Neurol; 2018 Sep; 265(9):2088-2096. PubMed ID: 29980853
[TBL] [Abstract][Full Text] [Related]
2. The motor inhibition system in Parkinson's disease with levodopa-induced dyskinesias.
Cerasa A; Donzuso G; Morelli M; Mangone G; Salsone M; Passamonti L; Augimeri A; Arabia G; Quattrone A
Mov Disord; 2015 Dec; 30(14):1912-20. PubMed ID: 26275050
[TBL] [Abstract][Full Text] [Related]
3. Age at onset influences neurodegenerative processes underlying PD with levodopa-induced dyskinesias.
Cerasa A; Salsone M; Morelli M; Pugliese P; Arabia G; Gioia CM; Novellino F; Quattrone A
Parkinsonism Relat Disord; 2013 Oct; 19(10):883-8. PubMed ID: 23769805
[TBL] [Abstract][Full Text] [Related]
4. Force overflow and levodopa-induced dyskinesias in Parkinson's disease.
Wenzelburger R; Zhang BR; Pohle S; Klebe S; Lorenz D; Herzog J; Wilms H; Deuschl G; Krack P
Brain; 2002 Apr; 125(Pt 4):871-9. PubMed ID: 11912119
[TBL] [Abstract][Full Text] [Related]
5. Motor cortex plasticity in Parkinson's disease and levodopa-induced dyskinesias.
Morgante F; Espay AJ; Gunraj C; Lang AE; Chen R
Brain; 2006 Apr; 129(Pt 4):1059-69. PubMed ID: 16476674
[TBL] [Abstract][Full Text] [Related]
6. The long-acting dopamine receptor agonist cabergoline in early Parkinson's disease: final results of a 5-year, double-blind, levodopa-controlled study.
Bracco F; Battaglia A; Chouza C; Dupont E; Gershanik O; Marti Masso JF; Montastruc JL;
CNS Drugs; 2004; 18(11):733-46. PubMed ID: 15330687
[TBL] [Abstract][Full Text] [Related]
7. Altered inhibitory interaction among inferior frontal and motor cortex in l-dopa-induced dyskinesias.
Ponzo V; Picazio S; Benussi A; Di Lorenzo F; Brusa L; Caltagirone C; Koch G
Mov Disord; 2016 May; 31(5):755-9. PubMed ID: 26861941
[TBL] [Abstract][Full Text] [Related]
8. Involvement of the subthalamic nucleus in impulse control disorders associated with Parkinson's disease.
Rodriguez-Oroz MC; López-Azcárate J; Garcia-Garcia D; Alegre M; Toledo J; Valencia M; Guridi J; Artieda J; Obeso JA
Brain; 2011 Jan; 134(Pt 1):36-49. PubMed ID: 21059746
[TBL] [Abstract][Full Text] [Related]
9. Non-homogeneous effect of levodopa on inhibitory circuits in Parkinson's disease and dyskinesia.
Barbin L; Leux C; Sauleau P; Meyniel C; Nguyen JM; Pereon Y; Damier P
Parkinsonism Relat Disord; 2013 Feb; 19(2):165-70. PubMed ID: 23000298
[TBL] [Abstract][Full Text] [Related]
10. The modern pre-levodopa era of Parkinson's disease: insights into motor complications from sub-Saharan Africa.
Cilia R; Akpalu A; Sarfo FS; Cham M; Amboni M; Cereda E; Fabbri M; Adjei P; Akassi J; Bonetti A; Pezzoli G
Brain; 2014 Oct; 137(Pt 10):2731-42. PubMed ID: 25034897
[TBL] [Abstract][Full Text] [Related]
11. Resting-state connectivity predicts levodopa-induced dyskinesias in Parkinson's disease.
Herz DM; Haagensen BN; Nielsen SH; Madsen KH; Løkkegaard A; Siebner HR
Mov Disord; 2016 Apr; 31(4):521-9. PubMed ID: 26954295
[TBL] [Abstract][Full Text] [Related]
12. AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study.
Stocchi F; Rascol O; Destee A; Hattori N; Hauser RA; Lang AE; Poewe W; Stacy M; Tolosa E; Gao H; Nagel J; Merschhemke M; Graf A; Kenney C; Trenkwalder C
Mov Disord; 2013 Nov; 28(13):1838-46. PubMed ID: 23853029
[TBL] [Abstract][Full Text] [Related]
13. Quantitative motor assessment of dyskinesias in Parkinson's disease.
Schaeffer E; Maetzler W; Liepelt-Scarfone I; Sass C; Reilmann R; Berg D
J Neural Transm (Vienna); 2015 Sep; 122(9):1271-8. PubMed ID: 25712401
[TBL] [Abstract][Full Text] [Related]
14. Cerebellar sensory processing alterations impact motor cortical plasticity in Parkinson's disease: clues from dyskinetic patients.
Kishore A; Popa T; Balachandran A; Chandran S; Pradeep S; Backer F; Krishnan S; Meunier S
Cereb Cortex; 2014 Aug; 24(8):2055-67. PubMed ID: 23535177
[TBL] [Abstract][Full Text] [Related]
15. A network centred on the inferior frontal cortex is critically involved in levodopa-induced dyskinesias.
Cerasa A; Koch G; Donzuso G; Mangone G; Morelli M; Brusa L; Stampanoni Bassi M; Ponzo V; Picazio S; Passamonti L; Salsone M; Augimeri A; Caltagirone C; Quattrone A
Brain; 2015 Feb; 138(Pt 2):414-27. PubMed ID: 25414038
[TBL] [Abstract][Full Text] [Related]
16. Levodopa-induced dyskinesias detection based on the complexity of involuntary movements.
Chelaru MI; Duval C; Jog M
J Neurosci Methods; 2010 Jan; 186(1):81-9. PubMed ID: 19878692
[TBL] [Abstract][Full Text] [Related]
17. Proficient motor impulse control in Parkinson disease patients with impulsive and compulsive behaviors.
Claassen DO; van den Wildenberg WP; Harrison MB; van Wouwe NC; Kanoff K; Neimat JS; Wylie SA
Pharmacol Biochem Behav; 2015 Feb; 129():19-25. PubMed ID: 25459105
[TBL] [Abstract][Full Text] [Related]
18. Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders.
Voon V; Fernagut PO; Wickens J; Baunez C; Rodriguez M; Pavon N; Juncos JL; Obeso JA; Bezard E
Lancet Neurol; 2009 Dec; 8(12):1140-9. PubMed ID: 19909912
[TBL] [Abstract][Full Text] [Related]
19. L-DOPA-induced dyskinesias, motor fluctuations and health-related quality of life: the COPARK survey.
Perez-Lloret S; Negre-Pages L; Damier P; Delval A; Derkinderen P; Destée A; Meissner WG; Tison F; Rascol O;
Eur J Neurol; 2017 Dec; 24(12):1532-1538. PubMed ID: 28940893
[TBL] [Abstract][Full Text] [Related]
20. Cortical response to levodopa in Parkinson's disease patients with dyskinesias.
Turco F; Canessa A; Olivieri C; Pozzi NG; Palmisano C; Arnulfo G; Marotta G; Volkmann J; Pezzoli G; Isaias IU
Eur J Neurosci; 2018 Sep; 48(6):2362-2373. PubMed ID: 30117212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]